A study of quality assessment in clinical microbiology performance of independent laboratories in Tokyo: 18-year participation in the Tokyo Metropolitan Government External Quality Assessment Program

2001 ◽  
Vol 7 (2) ◽  
pp. 102-109 ◽  
Author(s):  
Kazunari Kumasaka ◽  
Kinya Kawano ◽  
Keizo Yamaguchi ◽  
Jun Igari ◽  
Keiko Minowa ◽  
...  
1994 ◽  
Vol 9 (1) ◽  
pp. 43-47 ◽  
Author(s):  
G.C. Zucchelli ◽  
A. Pilo ◽  
M.R. Chiesa ◽  
S. Masini ◽  
A. Clerico

Immunoassays of the tumor markers CA 19.9, CA125 and CA 15.3 are generally acknowledged to be a useful tool in the management of cancer patients. As a consequence, many methods developed by different companies are now commercially available. However, discrepancies have been described in the results of marker determinations even when the same monoclonal antibody was used. An external quality assessment (EQA) was carried out; starting from 1989 about 110 laboratories participated; since December 1991 the program was linked with the interlaboratory program Oncocheck organized by the Service de Radiopharmacie et Radioanalyse, University of Lyon. At present more than 200 laboratories of many European countries are involved: cumulatively 47 quality control samples have been prepared and sent to the participants. This manuscript is a report on data collected for CA 19.9, CA 125, and CA 15.3.


2016 ◽  
Vol 49 (7-8) ◽  
pp. 601-605 ◽  
Author(s):  
Marco Salvatore ◽  
Giovanna Floridia ◽  
Annalisa Amato ◽  
Federica Censi ◽  
Claudio Carta ◽  
...  

2019 ◽  
Vol 65 (03/2019) ◽  
Author(s):  
Falin He ◽  
Wei Wang ◽  
Chaowen Yu ◽  
Kun Zhong ◽  
Shuai Yuan ◽  
...  

2005 ◽  
Vol 66 (8) ◽  
pp. 20
Author(s):  
Raja Rajalingam ◽  
Marie Lau ◽  
Zeying Du ◽  
Arlene Locke ◽  
John Muramoto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document